Skip to main content
SpringerLink
Log in

Morning plasma free cortisol: Inability to distinguish patients with mild Cushing syndrome from patients with pseudo-Cushing states

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Patients with Cushing syndrome have elevated 24 h urinary free cortisol excretion and loss of diurnal rhythm of plasma cortisol, however, morning total plasma cortisol concentrations are often similar to those of normal individuals. To test the hypothesis that an elevated morning plasma free cortisol could distinguish patients with Cushing syndrome from those without the disorder, we measured plasma free cortisol levels at 08:00 in 20 patients with surgically-confirmed mild Cushing syndrome, 19 patients with pseudo-Cushing states, and 9 normal volunteers. We then determined the sensitivity, specificity and diagnostic accuracy of plasma free cortisol for the diagnosis of hypercortisolism and for the diagnosis of Cushing syndrome. Plasma free cortisol was compared to 08:00 total plasma cortisol and to basal 24 hour urinary free cortisol. Morning plasma free cortisol was significantly elevated in patients with mild Cushing syndrome (58±6 nmol/L; mean±SE) compared to plasma free cortisol in patients with pseudo-Cushing states (36±6 nmol/L) (ps<0.005) and normal volunteers (22±4 nmol/L) (ps<0.0005). Total morning cortisol was significantly greater in patients with mild Cushing syndrome (470±28 nmol/L) than in normal volunteers (310±33 nmol/L, ps<0.05) but was not different from patients with pseudo-Cushing states (410±47 nmol/L, p=NS). Urinary free cortisol was also significantly greater in mild Cushing syndrome (540±50 nmol/d) than in patients with pseudo-Cushing states (430±41 nmol/d, p<0.05) or normal volunteers (160±28 nmol/d, p<0.0001). However, there was considerable overlap of plasma free cortisol, plasma total cortisol and urinary free cortisol between the three groups precluding these tests alone from being useful to distinguish patients with mild Cushing syndrome from patients with pseudo-Cushing states. To achieve 100% sensitivity for the diagnosis of Cushing syndrome, the specificity for plasma free cortisol, plasma total cortisol and urinary free cortisol was 0.11, 0.32 and 0.32, respectively. We conclude that plasma free cortisol is of limited value in the differential diagnosis of hypercortisolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Daughaday W.H. Binding of corticosteroids by human plasma proteins. IV. The electrophoretic demonstration of corticosteroid binding globulin. J. Clin. Endocrinol. Metab. 37: 519, 1958.

    CAS  Google Scholar 

  2. Slaunwhite W.R., Lockie G.N., Back N., Sandberg A.A. Inactivity in vivo of transcortin-bound cortisol. Science 135: 1062, 1962.

    Article  PubMed  CAS  Google Scholar 

  3. Brien T.G. Free cortisol in human plasma. Horm. Metab. Res. 12: 643, 1980.

    Article  PubMed  CAS  Google Scholar 

  4. Doe R.P., Zinneman H.H., Flink H.B., Ulstrom R.A. Significance of the concentration of non protein bound plasma cortisol in normal subjects, Cushing’s syndrome, pregnancy and during estrogen therapy. J. Clin. Endocrinol. Metab. 20: 1484, 1960.

    Article  PubMed  CAS  Google Scholar 

  5. Doe R.P., Fernandez R., Seal U.S. Measurement of corticosteroid binding globulin in man. J. Clin. Endocrinol. Metab. 24: 1029, 1964.

    Article  PubMed  CAS  Google Scholar 

  6. Sandberg A.A., Slaunwhite W.R. Transcortin: a corticosteroid binding protein in plasma. II. Levels in various conditions and the effect of estrogens. J. Clin. Invest. 38: 1290, 1959.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  7. Musa B.U., Seal U.S., Doe R.P. Serum protein alterations in women by synthetic estrogens. J. Clin. Endocrinol. Metab. 27: 1463, 1967.

    Article  PubMed  CAS  Google Scholar 

  8. Luton J.-P., Cedras S., Billaud L., Thomas G., Guilhaume B., Bertagna X., Laudat M.-H., Louvel A., Chapius Y., Blondeau P., Bonnin A., Bricaire H. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N. Engl. J. Med. 322: 1195, 1990.

    Article  PubMed  CAS  Google Scholar 

  9. Perini G.I., Devinsky O., Hauser P., Gallucci W.T., Theodore W.H., Chrousos G.P., Gold P.W., Kling M.A. Effects of carbamazepine on pituitary-adrenal function in healthy volunteers. J. Clin. Endocrinol. Metab. 74: 406, 1992.

    PubMed  CAS  Google Scholar 

  10. Nieman L.K., Chrousos G.P., Schulte H.M., Loriaux D.L., Nisula B.C. Adrenal regulation of corticosteroid-binding globulin (CBG). 7th International Congress of Endocrinology (Abstract) 1672, 1984.

  11. Frairia R., Agrimonti F., Fortunati N., Fazzari A., Gennari P., Berta L. Influence of naturally occurring and synthetic glucocorticoids on corticosteroid-binding globulin-steroid interaction in human peripheral plasma. Ann. N.Y. Acad. Sci. 538: 287, 1988.

    Article  PubMed  CAS  Google Scholar 

  12. Schlechte JA, Hamilton D. The effect of glucocorticoids on corticosteroid binding globulin. Clin. Endocrinol. 27: 197, 1987.

    Article  CAS  Google Scholar 

  13. Robin P., Pedine J., Milgrom E. Assay of unbound cortisol in plasma. J. Clin. Endocrinol. Metab. 46: 277, 1977.

    Article  Google Scholar 

  14. Burke C.W., Roulet F. Increased exposure of tissues to cortisol in late pregnancy. Br. Med. J. 1: 657, 1970.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  15. Murray D. Cortisol binding to plasma proteins in man in health, stress and at death. J. Endocrinol. 39: 571, 1967.

    Article  PubMed  CAS  Google Scholar 

  16. Kley H.K., Bartmann E., Kruskemper H.L. A simple and rapid method to measure non-protein bound fractions of cortisol, testosterone and oestradiol by equlibrium dialysis: comparison with centrifugal filtration. Acta Endocrinol. (Copenh.) 85: 209, 1977.

    CAS  Google Scholar 

  17. Yanovski J.A., Cutler G.B. Jr., Chrousos G.P., Nieman L.K. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration: A new test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. J. Am. Med. Assoc. 269: 2232, 1993.

    Article  CAS  Google Scholar 

  18. Jerkunica I., Sophianopoulos J., Sgoutas D. Improved ultrafiltration method for determining unbound cortisol in plasma. Clin. Chem. 26: 1734, 1980.

    PubMed  CAS  Google Scholar 

  19. Foster L.B., Dunn R.T. Single-antibody technique for radioimmunoassay of cortisol in unextracted serum or plasma. Clin. Chem. 20: 365, 1974.

    PubMed  CAS  Google Scholar 

  20. Ruder H.J., Guy R.L., Lipsett M.B. A radioimmunoassay for cortisol in plasma and urine. J. Clin. Endocrin. Metab. 35: 219, 1972.

    Article  CAS  Google Scholar 

  21. Brownlee K.A. The correlated two × two table. In: Shewhart W.A., Wilks S.S., Bradley R.A., Hunter S.J., Kendall D.G., Watson G.S. (Eds.), Statistical theory and methodology in science and engineering. Wiley and Sons, New York, 1984, p. 262.

    Google Scholar 

  22. Swets J.A. Measuring the accuracy of diagnostic systems. Science 240: 1285, 1988.

    Article  PubMed  CAS  Google Scholar 

  23. Crapo LM. Cushing’s syndrome: a review of diagnostic tests. Metab. 28: 955, 1979.

    Article  CAS  Google Scholar 

  24. Gold P.W., Loriaux D.L., Roy A., Kellner C.H., Post R.M., Kling MA, Calabrese J.R., Oldfield E.H., Pickar D., Avgerinos P.C., Paul S.M., Cutler Jr. G.B., Chrousos G.C. Physiology of hypercortisolism in depression and Cushing’s disease. N. Engl. J. Med. 314: 1329, 1986.

    Article  PubMed  CAS  Google Scholar 

  25. Gold P.W., Kling M.A., Whitfield H.J., Rabin D., Margioris A., Kalogeras K., Demitrack M., Loriaux D.L., Chrousos G.P. The clinical implications of corticotropin-releasing hormone. Adv. Exp. Med. Biol. 245: 507, 1988.

    Article  PubMed  CAS  Google Scholar 

  26. Besser G.M., Edwards C.R.W. Cushing’s syndrome. In: Mason A.S. (Ed.), Clinics in Endocrinology and Metabolism. WB Saunders, London, 1972, p. 451.

    Google Scholar 

  27. James V.H.T., Landon J., Wynn V. A fundamental defect of adrenocortical control in Cushing’s disease. J. Endocrinol. 40: 15, 1968.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Developmental Neurobiology, USA

    Theodore C. Friedman M.D., Ph.D.

  2. Developmental Endocrinology Branch NICHD, NIH, Bethesda, Maryland, USA

    Theodore C. Friedman M.D., Ph.D. & J. A. Yanovski

Authors
  1. Theodore C. Friedman M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. A. Yanovski
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Friedman, T.C., Yanovski, J.A. Morning plasma free cortisol: Inability to distinguish patients with mild Cushing syndrome from patients with pseudo-Cushing states. J Endocrinol Invest 18, 696–701 (1995). https://doi.org/10.1007/BF03349791

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349791

Key-words

Search

Navigation